Is Airway Remodeling Clinically Relevant in Asthma?

American Journal of Medicine

Volumn 115, Issue 8, 2003, Pages 652-659

  Lazaar, Aili L ^a   Panettieri Jr , Reynold A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT;

AIRWAY; ANGIOGENESIS; ASTHMA; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE COURSE; HEALING; HUMAN; HYPERACTIVITY; HYPERTROPHY; INFLAMMATION; LUNG FUNCTION; MUCUS GLAND; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROPHYLAXIS; RESPIRATORY EPITHELIUM; REVIEW; SPIROMETRY; SYMPTOM;

EID: 0344737744     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2003.07.010     Document Type: Review

References (90)

1. Busse W., Elias J., Sheppard D., Banks-Schlegel S. Airway remodeling and repair. Am J Respir Crit Care Med. 160:1999;1035-1042.
2. Gern J.E., Lemanske R.F. Jr, Busse W.W. Early life origins of asthma. J Clin Invest. 104:1999;837-843.
3. Lange P., Parner J., Vestbo J., Schnohr P., Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med. 339:1998;1194-1200.
4. Zeiger R.S., Dawson C., Weiss S. Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP). J Allergy Clin Immunol. 103:1999;376-387.
5. ten Brinke A., Zwinderman A.H., Sterk P.J., Rabe K.F., Bel E.H. Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med. 164:2001;744-748.
6. Kelly W.J., Hudson I., Raven J., Phelan P.D., Pain M.C., Olinsky A. Childhood asthma and adult lung function. Am Rev Respir Dis. 138:1988;26-30.
7. Grol M.H., Gerritsen J., Vonk J.M., et al. Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study. Am J Respir Crit Care Med. 160:1999;1830-1837.
8. Rasmussen F., Taylor D.R., Flannery E.M., et al. Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/vital capacity ratio a longitudinal population study from childhood to adulthood . Am J Respir Crit Care Med. 165:2002;1480-1488.
9. Oswald H., Phelan P.D., Lanigan A., et al. Childhood asthma and lung function in mid-adult life. Pediatr Pulmonol. 23:1997;14-20.
10. Ulrik C.S., Backer V., Dirksen A. A 10 year follow up of 180 adults with bronchial asthma factors important for the decline in lung function . Thorax. 47:1992;14-18.
11. Boezen H.M., Schouten J.P., Postma D.S., Rijcken B. Relation between respiratory symptoms, pulmonary function and peak flow variability in adults. Thorax. 50:1995;121-126.
12. Stevenson E.C., Turner G., Heaney L.G., et al. Bronchoalveolar lavage findings suggest two different forms of childhood asthma. Clin Exp Allergy. 27:1997;1027-1035.
13. Wenzel S.E., Schwartz L.B., Langmack E.L., et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med. 160:1999;1001-1008.
14. Pohunek P., Roche W.R., Turzikova J., Kurdman J., Warner J.O. Eosinophilic inflammation in the bronchial mucosa of children with bronchial asthma. Eur Respir J. 10:1997;160S.
15. Leckie M.J., ten Brinke A., Khan J., et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet. 356:2000;2144-2148.
16. Bates C.A., Silkoff P.E. Exhaled nitric oxide in asthma from bench to bedside . J Allergy Clin Immunol. 111:2003;256-262.
17. Kelly W.J., Hudson I., Phelan P.D., Pain M.C., Olinsky A. Atopy in subjects with asthma followed to the age of 28 years. J Allergy Clin Immunol. 85:1990;548-557.
18. Stein R.T., Holberg C.J., Morgan W.J., et al. Peak flow variability, methacholine responsiveness and atopy as markers for detecting different wheezing phenotypes in childhood. Thorax. 52:1997;946-952.
19. Martinez F.D., Wright A.L., Taussig L.M., Holberg C.J., Halonen M., Morgan W.J. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med. 332:1995;133-138.
20. Tracey M., Villar A., Dow L., Coggon D., Lampe F.C., Holgate S.T. The influence of increased bronchial responsiveness, atopy, and serum IgE on decline in FEV1. A longitudinal study in the elderly. Am J Respir Crit Care Med. 151:1995;656-662.
21. Jeffery P.K., Wardlaw A.J., Nelson F.C., Collins J.V., Kay A.B. Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis. 140:1989;1745-1753.
22. Beasley R., Roche W.R., Roberts J.A., Holgate S.T. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis. 139:1989;806-817.
23. Roche W.R., Williams J.H., Beasley R., Holgate S.T. Subepithelial fibrosis in the bronchi of asthmatics. Lancet. 1:1989;520-524.
24. Ordonez C., Ferrando R., Hyde D.M., Wong H.H., Fahy J.V. Epithelial desquamation in asthma artifact or pathology? Am J Respir Crit Care Med. 162:2000;2324-2329.
25. Lozewicz S., Wells C., Gomez E., et al. Morphological integrity of the bronchial epithelium in mild asthma. Thorax. 45:1990;12-15.
26. Holgate S.T., Lackie P.M., Howarth P.H., et al. Invited lecture activation of the epithelial mesenchymal trophic unit in the pathogenesis of asthma . Int Arch Allergy Immunol. 124:2001;253-258.
27. Laitinen A., Altraja A., Kampe M., Linden M., Virtanen I., Laitinen L.A. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med. 156:1997;951-958.
28. Johnson P.R. Role of human airway smooth muscle in altered extracellular matrix production in asthma. Clin Exp Pharmacol Physiol. 28:2001;233-236.
29. Chakir J., Laviolette M., Boutet M., Laliberte R., Dube J., Boulet L.P. Lower airways remodeling in nonasthmatic subjects with allergic rhinitis. Lab Invest. 75:1996;735-744.
30. Chu H.W., Halliday J.L., Martin R.J., Leung D.Y., Szefler S.J., Wenzel S.E. Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease. Am J Respir Crit Care Med. 158:1998;1936-1944.
31. Laitinen L.A., Laitinen A., Altraja A., et al. Bronchial biopsy findings in intermittent or "early" asthma. J Allergy Clin Immunol. 98:(suppl):1996;S3-S6.
32. Boulet L.P., Turcotte H., Laviolette M., et al. Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Influence of inhaled corticosteroids. Am J Respir Crit Care Med. 162:2000;1308-1313.
33. Payne D.N., Rogers A.V., Adelroth E., et al. Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med. 167:2003;78-82.
34. Chetta A., Foresi A., Del Donno M., Bertorelli G., Pesci A., Olivieri D. Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest. 111:1997;852-857.
35. Minshall E.M., Leung D.Y., Martin R.J., et al. Eosinophil-associated TGF-β1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol. 17:1997;326-333.
36. Hoshino M., Nakamura Y., Sim J., Shimojo J., Isogai S. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J Allergy Clin Immunol. 102:1998;783-788.
37. Wilson J.W., Li X. The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway. Clin Exp Allergy. 27:1997;363-371.
38. Roberts C.R. Is asthma a fibrotic disease? Chest. 107:(suppl):1995;111S- 117S.
39. Johns D.P., Wilson J., Harding R., Walters E.H. Airway distensibility in healthy and asthmatic subjects effect of lung volume history . J Appl Physiol. 88:2000;1413-1420.
40. Frey U., Makkonen K., Wellman T., Beardsmore C., Silverman M. Alterations in airway wall properties in infants with a history of wheezing disorders. Am J Respir Crit Care Med. 161:2000;1825-1829.
41. Ward C., Johns D.P., Bish R., et al. Reduced airway distensibility, fixed airflow limitation, and airway wall remodeling in asthma. Am J Respir Crit Care Med. 164:2001;1718-1721.
42. Altraja A., Laitinen A., Virtanen I., et al. Expression of laminins in the airways in various types of asthmatic patients a morphometric study . Am J Respir Cell Mol Biol. 15:1996;482-488.
43. Huang J., Olivenstein R., Taha R., Hamid Q., Ludwig M. Enhanced proteoglycan deposition in the airway wall of atopic asthmatics. Am J Respir Crit Care Med. 160:1999;725-729.
44. Westergren-Thorsson G., Chakir J., Lafreniere-Allard M.J., Boulet L.P., Tremblay G.M. Correlation between airway responsiveness and proteoglycan production by bronchial fibroblasts from normal and asthmatic subjects. Int J Biochem Cell Biol. 34:2002;1256-1267.
45. Bousquet J., Lacoste J.Y., Chanez P., Vic P., Godard P., Michel F.B. Bronchial elastic fibers in normal subjects and asthmatic patients. Am J Respir Crit Care Med. 153:1996;1648-1654.
46. Gelb A.F., Licuanan J., Shinar C.M., Zamel N. Unsuspected loss of elastic recoil in chronic persistent asthma. Chest. 121:2002;673-674.
47. Ordonez C.L., Khashayar R., Wong H.H., et al. Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. Am J Respir Crit Care Med. 163:2001;517-523.
48. Groneberg D.A., Eynott P.R., Lim S., et al. Expression of respiratory mucins in fatal status asthmaticus and mild asthma. Histopathology. 40:2002;367-373.
49. Huber H.L., Koessler K.K. The pathology of bronchial asthma. Arch Intern Med. 30:1922;689-760.
50. Heard B.E., Hossain S. Hyperplasia of bronchial muscle in asthma. J Pathol. 110:1973;319-331.
51. Wiggs B.R., Bosken C., Pare P.D., James A., Hogg J.C. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis. 145:1992;1251-1258.
52. Macklem P.T. A theoretical analysis of the effect of airway smooth muscle load on airway narrowing. Am J Respir Crit Care Med. 153:1996;83-89.
53. Carroll N., Elliot J., Morton A., James A. The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis. 147:1993;405-410.
54. Kuwano K., Bosken C.H., Pare P.D., Bai T.R., Wiggs B.R., Hogg J.C. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis. 148:1993;1220-1225.
55. Bai T.R., Cooper J., Koelmeyer T., Pare P.D., Weir T.D. The effect of age and duration of disease on airway structure in fatal asthma. Am J Respir Crit Care Med. 162:2000;663-669.
56. Cho S.H., Seo J.Y., Choi D.C., et al. Pathological changes according to the severity of asthma. Clin Exp Allergy. 26:1996;1210-1219.
57. Benayoun L., Druilhe A., Dombret M.C., Aubier M., Pretolani M. Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med. 167:2003;1360-1368.
58. Li X., Wilson J.W. Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med. 156:1997;229-233.
59. Salvato G. Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects. Thorax. 56:2001;902-906.
60. Chu H.W., Kraft M., Rex M.D., Martin R.J. Evaluation of blood vessels and edema in the airways of asthma patients regulation with clarithromycin treatment . Chest. 120:2001;416-422.
61. Carroll N.G., Cooke C., James A.L. Bronchial blood vessel dimensions in asthma. Am J Respir Crit Care Med. 155:1997;689-695.
62. Kumar S.D., Emery M.J., Atkins N.D., Danta I., Wanner A. Airway mucosal blood flow in bronchial asthma. Am J Respir Crit Care Med. 158:1998;153-156.
63. Vrugt B., Wilson S., Bron A., Holgate S.T., Djukanovic R., Aalbers R. Bronchial angiogenesis in severe glucocorticoid-dependent asthma. Eur Respir J. 15:2000;1014-1021.
64. Orsida B.E., Li X., Hickey B., Thien F., Wilson J.W., Walters E.H. Vascularity in asthmatic airways relation to inhaled steroid dose . Thorax. 54:1999;289-295.
65. Goldin J.G. Quantitative CT of the lung. Radiol Clin North Am. 40:2002;145-162.
66. Awadh N., Muller N.L., Park C.S., Abboud R.T., Fitzgerald J.M. Airway wall thickness in patients with near fatal asthma and control groups assessment with high resolution computed tomographic scanning . Thorax. 53:1998;248-253.
67. Little S.A., Sproule M.W., Cowan M.D., et al. High resolution computed tomographic assessment of airway wall thickness in chronic asthma reproducibility and relationship with lung function and severity . Thorax. 57:2002;247-253.
68. Harmanci E., Kebapci M., Metintas M., Ozkan R. High-resolution computed tomography findings are correlated with disease severity in asthma. Respiration. 69:2002;420-426.
69. Kasahara K., Shiba K., Ozawa T., Okuda K., Adachi M. Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma. Thorax. 57:2002;242-246.
70. Paganin F., Seneterre E., Chanez P., et al. Computed tomography of the lungs in asthma influence of disease severity and etiology . Am J Respir Crit Care Med. 153:1996;110-114.
71. Taylor I.K., Hill A.A., Hayes M., et al. Imaging allergen-invoked airway inflammation in atopic asthma with (18F)-fluorodeoxyglucose and positron emission tomography. Lancet. 347:1996;937-940.
72. Altes T.A., Powers P.L., Knight-Scott J., et al. Hyperpolarized 3He MR lung ventilation imaging in asthmatics preliminary findings . J Magn Reson Imaging. 13:2001;378-384.
73. de Lange E.E., Mugler J.P. III, Brookeman J.R., et al. Lung air spaces MR imaging evaluation with hyperpolarized 3He gas . Radiology. 210:1999;851-857.
74. Pitris C., Brezinski M.E., Bouma B.E., Tearney G.J., Southern J.F., Fujimoto J.G. High resolution imaging of the upper respiratory tract with optical coherence tomography a feasibility study . Am J Respir Crit Care Med. 157:1998;1640-1644.
75. van den Toorn L.M., Overbeek S.E., de Jongste J.C., Leman K., Hoogsteden H.C., Prins J.B. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med. 164:2001;2107-2113.
76. de Kluijver J., Evertse C.E., Schrumpf J.A., et al. Asymptomatic worsening of airway inflammation during low-dose allergen exposure in asthma protection by inhaled steroids . Am J Respir Crit Care Med. 166:2002;294-300.
77. Olivieri D., Chetta A., Del Donno M., et al. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma a placebo-controlled study . Am J Respir Crit Care Med. 155:1997;1864-1871.
78. Hoshino M., Takahashi M., Takai Y., Sim J. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J Allergy Clin Immunol. 104:1999;356-363.
79. Ward C., Pais M., Bish R., et al. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax. 57:2002;309-316.
80. Hoshino M., Takahashi M., Takai Y., Sim J., Aoike N. Inhaled corticosteroids decrease vascularity of the bronchial mucosa in patients with asthma. Clin Exp Allergy. 31:2001;722-730.
81. Chetta A., Zanini A., Foresi A., et al. Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone. Am J Respir Crit Care Med. 167:2003;751-757.
82. Hoshino M., Nakamura Y., Sim J.J., et al. Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-I expression in bronchial asthma. Clin Exp Allergy. 28:1998;568-577.
83. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med. 343:2000;1054-1063.
84. Sont J.K., Willems L.N., Bel E.H., van Krieken J.H., Vandenbroucke J.P., Sterk P.J. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med. 159:1999;1043-1051.
85. Crimi E., Spanevello A., Neri M., Ind P.W., Rossi G.A., Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med. 157:1998;4-9.
86. Haahtela T., Jarvinen M., Kava T., et al. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med. 325:1991;388-392.
87. Selroos O., Pietinalho A., Lofroos A.B., Riska H. Effect of early vs. late intervention with inhaled corticosteroids in asthma. Chest. 108:1995;1228-1234.
88. Orsida B.E., Ward C., Li X., et al. Effect of a long-acting beta2-agonist over three months on airway wall vascular remodeling in asthma. Am J Respir Crit Care Med. 164:2001;117-121.
89. Tomlinson P.R., Wilson J.W., Stewart A.G. Inhibition by salbutamol of the proliferation of human airway smooth muscle cells grown in culture. Br J Pharmacol. 111:1994;641-647.
90. Henderson W.R. Jr, Tang L.O., Chu S.J., et al. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med. 165:2002;108-116.